Tin tức & Cập nhật
Xem bài viết Multidisciplinary
Xem
Chỉ hiển thị Multimedia

Benralizumab helps maintain severe asthma control with reduced ICS doses
22 Sep 2023
bởiJairia Dela Cruz
Treatment with benralizumab allows tapering of inhaled corticosteroid (ICS) doses for patients with severe eosinophilic asthma, without compromising disease control and increasing exacerbations, as shown in the results of the phase IV SHAMAL study.








